Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALNY · against 105 other Healthcare companies of similar size
Ranked #94 of 106 · scores higher than 11% of peers · safety percentile 12
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)18 peers with a safety percentile of 10–19, including ALNY · Click a bar to see the companies
Mainly because of its debt / equity, which is weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ALNY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 103 reported | 2.21× | 0.44× | 6% | 33% | |
| BetaLower is better · 105 reported | 0.27 | 0.69 | 80% | 33% | |
| Current ratioHigher is better · 101 reported | 3.06× | 1.91× | 77% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 10.1B EUR (≈$11.1B) | 99 | ||
| 2 | 26.0B USD | 93 | 28 | |
| 3 | 12.6B USD | 89 | ||
| 4 | 20.0B AUD (≈$13.2B) | 84 | 77 | |
| 5 | 25.8B USD | 83 | 75 | |
| 90 | 16.9B USD | 14 | 37 | |
| 91 | 15.8B EUR (≈$17.4B) | 13 | 47 | |
| 92 | 73.2B SAR (≈$19.8B) | 13 | 56 | |
| 93 | 111.7B DKK (≈$16.8B) | 12 | 53 | |
| 94 | 21.4B USD | 12 | 67 | |
| 95 | 13.8B USD | 12 | 54 | |
| 96 | 77.1B DKK (≈$11.6B) | 11 | 47 | |
| 97 | 68.0B BRL (≈$12.2B) | 10 | 67 | |
| 98 | 34.3B USD | 9 | 57 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score